Position in BIOA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
3 quarters on record
Derivatives in BIOA
reported options exposure · as of Mar 31, 2026CallValue
$271,095
CallShares
15,500
PutValue
$190,641
PutShares
10,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $182,242,360 across 41 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,464,638 | $44,114,896 | |
| 2 | LQDA |
Liquidia Corp
|
795,884 | $30,036,661 | |
| 3 | VTRS |
Viatris Inc
|
2,192,665 | $29,622,903 | |
| 4 | HLN |
Haleon plc
|
2,291,768 | $22,940,596 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
622,607 | $5,927,217 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
240,170 | $4,985,929 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
1,030,050 | $4,274,707 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
725,616 | $4,208,572 |
All Filings in BIOA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $271,095 | 15,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $190,641 | 10,900 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $244,755 | 18,500 | Call | Defined | 2026-02-12 | |
| 2024-09-30 | $895,918 | 43,073 | Shares | Defined | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||